We are in clinical trial at the moment.
Taking Venus Medtech for comparison (see attached diagram extracted from VM's IPO prospectus), we are probably 12 - 24 months behind.
Venus Medtech currently has a market cap of US$4 Billion.
DYOR!!!
New AVR detailed research report with valuations, page-58
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.81 |
Change
-0.190(1.06%) |
Mkt cap ! $342.3M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $53.63K | 2.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 106 | $17.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.92 | 47 | 3 |
View Market Depth
| Last trade - 15.30pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |